Lactobacillus reuteri DSM 17938 in Infantile Colic: A Randomized, Double-Blind, Placebo-Controlled Trial
- 2010-09-01
- RCT · n = 50
- Pediatrics 126(3)
- F. Savino
- Lisa Cordisco
- V. Tarasco
- E. Palumeri
- R. Calabrese
- R. Oggero
- S. Roos
- D. Matteuzzi
- PubMed: 20713478
- DOI: 10.1542/peds.2010-0433
22 Insights on
- Increased Fecal Lactobacilli
- Reduced Crying Duration
- Stable Body Weight
- Reduced Ammonia Levels
- No Adverse Events Observed
- Reduced Crying in Infants
- Increased Response Rate
- Reduced Fecal Escherichia coli Levels
- Reduced Fecal Ammonia Levels
- Increased Treatment Responders
- Reduced Incidence of Constipation
- Absence of Adverse Events
- Reduced Crying Time
- No Change in Weight Gain
- Reduced Infant Colics
- Reduced Crying Time in Infants with Colic
- No Adverse Events from Supplementation
- Improved Colic Symptoms
- Increased Number of Responders with Reduced Crying Time
- Improved Response Rate
- Unchanged Stool Frequency
- Weight Gain Consistency
- High evidence
- Highly Cited